The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Compare

605 Followers

Genmab (GMAB) Ownership Overview

1.15% Mutual Funds

2.37% Other Institutional Investors

0.84% ETFs

95.63% Public Companies and Individual Investors

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 4.37% of the company’s stock is owned by Institutional Investors, and 95.63% is owned by Public Companies and Individual Investors.

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 3.22% of the company’s stock is owned by Institutional Investors, 1.15% is owned by Insiders, and 95.63% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2024	Fortitude Family Office, Llc	xxxxxxxxxxxxx	$876

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	4,509,043	Institution	0.68%	96,042,616
	3,296,337	Institution	0.50%	70,211,978
	2,285,855	Institution	0.35%	48,688,712
	1,742,576	Institution	0.26%	37,116,869
	362,815	Institution	0.05%	7,727,960
Roberto Mignone	291,500	Institution	0.04%	6,208,950
	213,836	Institution	0.03%	4,554,707
	150,394	Institution	0.02%	3,203,392
	129,000	Institution	0.02%	2,747,700
	122,758	Institution	0.02%	2,614,745

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
4,509,043	Institution	0.68%	96,042,616
2,285,855	Institution	0.35%	48,688,712
362,815	Institution	0.05%	7,727,960
129,000	Institution	0.02%	2,747,700
122,758	Institution	0.02%	2,614,745
72,374	Institution	0.01%	1,541,566
59,210	Institution	<0.01%	1,261,173
30,647	Institution	<0.01%	652,781
27,016	Institution	<0.01%	575,441
21,600	Institution	<0.01%	460,080

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	3,255,205	Institution	0.49%	69,335,867
First Trust NYSE Arca Biotechnology Index Fund	1,729,906	Institution	0.26%	36,846,998
Fidelity Enhanced International ETF	197,440	Institution	0.03%	4,130,445
Avantis International Equity ETF	145,682	Institution	0.02%	3,047,667
Tema Oncology ETF	119,207	Institution	0.02%	2,493,810
Dimensional International Core Equity Market ETF	22,620	Institution	<0.01%	473,210
iShares NASDAQ US Biotechnology UCITS ETF	20,633	Institution	<0.01%	431,642
ActivePassive International Equity ETF	20,499	Institution	<0.01%	428,839
Fidelity Nasdaq Composite Index ETF	16,695	Institution	<0.01%	348,425
First Trust NYSE Arca Biotechnology UCITS ETF	12,670	Institution	<0.01%	269,871

FAQ

Who Owns Genmab A/S (GMAB)?

Currently, no data Available

What percentage of Genmab A/S (GMAB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.37% of Genmab A/S (GMAB) stock is held by institutional investors.

What percentage of Genmab A/S (GMAB) stock is held by retail investors?

According to the latest TipRanks data, approximately 95.63% of Genmab A/S (GMAB) stock is held by retail investors.

Who owns the most shares of Genmab A/S (GMAB)?

AB LARGE CAP GROWTH FUND INC owns the most shares of Genmab A/S (GMAB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing